Market Research Report
In Vitro Diagnostics - Global Market Outlook (2018-2027)
|Published by||Stratistics Market Research Consulting||Product code||932651|
|Published||Content info||187 Pages
Delivery time: 2-3 business days
|In Vitro Diagnostics - Global Market Outlook (2018-2027)|
|Published: March 1, 2020||Content info: 187 Pages||
According to Stratistics MRC, the Global In Vitro Diagnostics Market is accounted for $87.93 billion in 2018 and is expected to reach $164.40 billion by 2027 growing at a CAGR of 7.2% during the forecast period. Increasing adoption of fully automated instruments in labs, rising awareness on personalized medicine and consequent growth of chronic diseases are the major factors driving the market growth. However, adverse reimbursement scenario is restraining the market growth.
In Vitro Diagnostics (IVD) consists of medical devices and consumables that are utilized to detect any kind of infection and diseases by taking the specimen from the human body to cure diseases or its sequelae and perform in vitro tests on various biological samples. These products can be instruments, reagents, or any system used for the diagnosis of diseases. They are used for the diagnosis of various medical conditions, such as diabetes and cancer.
Based on end user, the point-of-care testing segment is likely to have a huge demand due rising requirements of these testing's as it includes biosensors, pregnancy kits and glucose meters to ensure quick and accurate results. By geography, North America is going to have a lucrative growth during the forecast period due to awareness among people regarding availability of innovative products and upsurge of strong prominent business players will lead to market growth.
Some of the key players profiled in the In Vitro Diagnostics Market include Abbott Laboratories Inc, Agilent Technologies, Becton Dickinson and Company, Biomerieux Sa, Bio-Rad Laboratories Inc, Cepheid, Danaher Corporation, Diasorin, Johnson & Johnson, Leica Biosystems Nussloch GmbH, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific.
End Users Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.